Reirradiation for Recurrent Glioblastoma: What We Know and What We Do Not
Mené entre 2012 et 2016 sur 170 patients atteints d'un glioblastome récidivant (durée médiane de suivi : 12,8 mois), cet essai randomisé multicentrique de phase II évalue l'efficacité, du point de vue de la survie globale, et la sécurité du bévacizumab associé à une seconde irradiation par rapport au bévacizumab seul
The Oncology Grand Rounds series is designed to place original reports published in the Journal into clinical context. A case presentation is followed by a description of diagnostic and management challenges, a review of the relevant literature, and a summary of the authors’ suggested management approaches. The goal of this series is to help readers better understand how to apply the results of key studies, including those published in Journal of Clinical Oncology, to patients seen in their own clinical practice.
Journal of Clinical Oncology , article en libre accès, 2021